Design and development of intraocular polymeric implant systems for long-term controlled-release of clindamycin phosphate for toxoplasmic retinochoroiditis
Background: The release of the anti-toxoplasmosis drug, clindamycin phosphate, from intraocular implants of the biodegradable polymers poly (D, L-lactic acid) (PLA) and poly (D, L-lactide-co-glycolide) (PLGA) has been studied in vitro. Materials and Methods: The preparation of the implants was perf...
Main Authors: | Lana Tamaddon, S Abolfazl Mostafavi, Reza Karkhane, Mohammad Riazi-Esfahani, Farid Abedin Dorkoosh, Morteza Rafiee-Tehrani |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2015-01-01
|
Series: | Advanced Biomedical Research |
Subjects: | |
Online Access: | http://www.advbiores.net/article.asp?issn=2277-9175;year=2015;volume=4;issue=1;spage=32;epage=32;aulast=Tamaddon |
Similar Items
-
Foveal reorganization after treatment of acute foveal toxoplasmic retinochoroiditis
by: Mojtaba Abrishami, et al.
Published: (2021-06-01) -
Intravitreal Clindamycin as First-Line Therapy for Toxoplasmic Retinochoroiditis: A Case Series
by: Verma L, et al.
Published: (2020-12-01) -
Treatment of toxoplasmic encephalitis with the combination of clindamycin plus azithromycin in an HIV‐infected patient: A case report
by: Keyhan Mohammadi, et al.
Published: (2021-05-01) -
An alternative synthesis of clindamycin
by: GRAHAM P. STEVENS, et al.
Published: (2000-10-01) -
Fulminant toxoplasmic retinochoroiditis following intravitreal triamcinolone administration
by: Ryan Rush, et al.
Published: (2012-01-01)